arrow
C

Christoph J. Auernhammer

LMU University Hospital
H指数:44
被引数:7,146

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

EP1108 - ECE_2149 - Nicotinamide phosphoribosyltransferase (NAMPT) inhibition—a novel metabolically-guided personalised therapy for neuroendocrine neoplasia

EP1108 - ECE_2149 - 尼克酰胺磷酸核糖转移酶(NAMPT)抑制——一种针对神经内分泌新生物的新型代谢引导个性化疗法

2026-08-100
OAAI
Personalized Drug Screening and Risk Assessment in Patient-Derived Gastroenteropancreatic Neuroendocrine Neoplasms

患者源性胃肠胰神经内分泌肿瘤的个性化药物筛选和风险评估

2026-01-010
PRE
Quantitative [18F]FDOPA PET/CT for the characterization of biochemical phenotypes in paraganglioma and pheochromocytoma

定量[18F]FDOPA PET/CT在副神经节瘤和嗜铬细胞瘤生化表型特征中的应用

2025-11-240
OA
[18F]SiTATE PET for PRRT selection and monitoring metastatic tumors of the adrenal medulla and extra-adrenal paraganglia

[18F]SiTATE PET用于选择和监测肾上腺髓质及肾上腺外副神经节瘤的转移性肿瘤

2025-09-190
PREAI
Predictors of renal function decline in patients with gastroenteropancreatic neuroendocrine tumors undergoing [177Lu]Lu-DOTA-TATE therapy

胃肠胰神经内分泌肿瘤患者接受[177Lu]Lu-DOTA-TATE治疗时肾功能下降的预测因素

2025-08-210
OAAI
Precision Oncology in Rare Endocrine and Neuroendocrine Neoplasms: Experiences and Challenges of the CCCMunichLMU Molecular Tumor Board

罕见内分泌及神经内分泌新生物的精准肿瘤学:CCCMunichLMU分子肿瘤委员会的经验与挑战

2025-06-300
OAAI
Comparison of the Hematotoxicity of PRRT with Lutathera® and Locally Manufactured 177Lu-HA-DOTATATE in Patients with Neuroendocrine Tumors and the Impact of Different Application Intervals

比较PRRT联合Lutathera®与国产177Lu-HA-DOTATATE在神经内分泌肿瘤患者中的血液毒性及不同应用间隔的影响

CANCERS
IF4.4
2025-04-240
OA
PET-and CT-Based Imaging Criteria for Response Assessment of Gastroenteropancreatic Neuroendocrine Tumors Under Radiopharmaceutical Therapy

基于PET和CT的影像学标准:放射性药物疗法下胃肠胰神经内分泌肿瘤的疗效评估

2025-03-270
PRE
Impact of sex hormones on pheochromocytomas, paragangliomas, and gastroenteropancreatic neuroendocrine tumors

性激素对嗜铬细胞瘤,副神经节瘤和胃肠胰腺神经内分泌肿瘤的影响

2025-01-101
PRE
Long-Term Persistence of Glycemic Dysregulation in Patients With a History of Pheochromocytoma/Paraganglioma
2025-01-020
OA
PET/CT imaging of differentiated and medullary thyroid carcinoma using the novel SSTR-targeting peptide [18F]SiTATE - first clinical experiences
2024-10-150
OAAI
Opposing Effects of Cannabidiol in Patient-derived Neuroendocrine Tumor, Pheochromocytoma/Paraganglioma Primary Cultures

大麻二酚在患者源性神经内分泌肿瘤,嗜铬细胞瘤/副神经节瘤原代培养物中的相反作用

2024-04-125
OA
Neuroendocrine liver metastases treated using transarterial radioembolization: Identification of prognostic parameters at 68Ga-DOTATATE PET/CT

经动脉放射栓塞治疗的神经内分泌肝转移: 68ga-dotatate PET/CT的预后参数鉴定

2024-01-012
PRE
Impact of the PI3K-alpha inhibitor alpelisib on everolimus resistance and somatostatin receptor expression in an orthotopic pancreatic NEC xenograft mouse model

PI3K-alpha抑制剂alpelisib对原位胰腺NEC异种移植小鼠模型依维莫司耐药性和生长抑素受体表达的影响

2023-11-090
PRE
Responses to systemic therapy in metastatic pheochromocytoma/paraganglioma: a retrospective multicenter cohort study

转移性嗜铬细胞瘤/副神经节瘤对全身治疗的反应: 一项回顾性多中心队列研究

2023-11-097
OA